Conivaptan
Back to searchMolecule Structure
Scientific Name
Conivaptan
Description of the Drug
Conivaptan is an antidiuretic hormone inhibitor used to raise serum sodium levels.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00872
http://www.drugbank.ca/drugs/DB00872
Brand Name(s)
Not Available
Company Owner(s)
Cumberland Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Vasopressin V1a receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1889 |
Vasopressin V2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1790 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL49815 | ||
PharmGKB | PA164742939 | ||
Human Metabolome Database | HMDB0015010 | ||
DrugBank | DB00872 | ||
PubChem: Thomson Pharma | 14933230 | ||
PubChem | 151171 | ||
LINCS | LSM-45291 | ||
Nikkaji | J818.497F | ||
BindingDB | 85095 | ||
EPA CompTox Dashboard | DTXSID80175220 | ||
DrugCentral | 732 | ||
Brenda | 253238 | ||
ChemicalBook | CB51011161 | ||
Guide to Pharmacology | 2203 | ||
rxnorm | VAPRISOL | CONIVAPTAN | CONIVAPTAN HYDROCHLORIDE |
ChEBI | 681850 | ||
ZINC | ZINC000012503187 |